Axogen, Inc. (AXGN)
30.41
+0.43
(+1.43%)
USD |
NASDAQ |
Dec 12, 14:34
Axogen Research and Development Expense (TTM): 27.24M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| IRIDEX Corp. | 3.832M |
| Stereotaxis, Inc. | 9.463M |
| Electromed, Inc. | 1.071M |
| Modular Medical, Inc. | 17.11M |
| Myomo, Inc. | 6.879M |